Clinical Trial Update: Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares topical photodynamic therapy using 5-aminolevulinic acid (20%) with two-stage methylaminolevulinate for superficial basal cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Basal Cell Carcinoma

Drugs mentioned

• 5-aminolevulinic acid (topical) 20% (5-aminolevulinic acid)
• Methyl aminolevulinate (topical) (methyl aminolevulinate)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Superficial Basal Cell Carcinoma | Phase 4 | Status: UNKNOWN